Hämostaseologie, Table of Contents Hamostaseologie 1983; 03(03): 102-106DOI: 10.1055/s-0038-1656625 Originalarbeiten Schattauer GmbH Hereditäre Dysfibrinogenämie E. A. Beck 1 Aus dem Hämatologischen Zentrallabor, Inselspital, Bern › Author AffiliationsRecommend Article Abstract Buy Article Full Text References LITERATUR 1 Beck E. A. Abnormal fibrinogen (fibrinogen »Baltimore«) as a cause of a familial hemorrhagic disorder. 1964; Blood 24: 853 2 Beck E. A, Duckert F. Congenital dysfibrino-genemia: fibrinogen Aarau. Proc. II Congr. Eur. Afr. Div. Intern. Soc. Hemat. 1973: 253 3 Beck E. A. Congenital disorders of fibrin formation and stabilization. In Colman R. W, Hirsh J, Marder V. J, Salzman E. W. (Hrsg.) Hemostasis and Thrombosis Lippincott; Philadelphia, Toronto: S.185-209. 1982 4 Blombäck M, Blombäck B, Mammen E. F, Prasad A. S. Fibrinogen »Detroit« – a molecular defect in the N-terminal disulphide knot of human fibrinogen?. Nature 1968; 218: 134-137. 5 Blombäck B, Blombäck M. Molecular defects and variants of fibrinogen. Nouv. Rev. Franç. Hémat 1970; 10: 671-678. 6 Budzynski A. Z, Marder V. J. Defect in the gamma polypeptide chain of a congenital abnormal fibrinogen (Paris I). Nature 1974; 252: 66-67. 7 Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haemat 1957; 17: 237-246. 8 Egeberg O. Inherited fibrinogen abnormality causing thrombophilia. Thrombos. Diathes. Haemorrh. (Stuttg.) 1967; 17: 176-187. 9 Francis J. L, Armstrong D. J. Acquired dysfibrinogenemia in liver disease. J. Clin. Pathol 1982; a 35: 667-672. 10 Francis J. L, Armstrong D. J. Fibrinogen-bound sialic acid levels in the dysfibrinogenemia of liver disease. Haemostasis 1982; b 77: 215-222. 11 Francis J. L, Armstrong D. J. Sialic acid and enzymatic desialation of cord blood fibrinogen. Haemostásis 1982; c 11: 223-228. 12 Gralnick H. R, Givelber H, Abrams E. Dysfibrinogenemia associated with hepatoma. N. Engl. J. Med 1978; 299: 221-226. 13 Gralnick H. R, Coller B. S, Fratantoni J. C, Martinez J. Fibrinogen Bethesda III: a hypo-dysfibrinogenemia. Blood 1979; 53: 28-46. 14 Heni F, Krauss I. Angeborene familiäre Gerinnungsstörung durch heparinartigen Hemmkörper. Klin. Wschr 1956; 34: 747-749. 15 Henschen A, Southan C. Methode zur Isolierung abnormer Fibrinogene aus Plasma. In Deutsch E, Lechner K. (Hrsg.) Fibrinolyse, Thrombose, Hämostase S.290-293. Schattauer; Stuttgart/New York: 1980 16 Henschen A, Kehl M, Southan C. Abnorme Fibrinogene: Beziehung zwischen Dysfunktion und Strukturfehler. In van de Loo J, Asbeck F. (Hrsg.) Hämostase, Thrombophilie und Arteriosklerose Schattauer; Stuttgart/New York: 1982: S.661-664. 17 Higgins D. L, Shafer J. A. Fibrinogen Petoskey, a dysfibrinogenemia characterized by replacement of Arg-AA16 by a histidyl residue. J. Biol. Chem 1981; 256: 12013-12017. 18 Imperato C, Dettori A. G. Ipofibrinogenemia congenita con fibrinoastenia. Helv. Paediat. Acta 1958; 13: 380-399. 19 Jackson D. P, Beck E. A, Charache P. Congenital disorders of fibrinogen. Feder. Proc 1965; 24: 816-821. 20 Kudryk B, Blombäck B, Blombäck M. Fibrinogen Detroit, an abnormal fibrinogen with nonfunctional NH2-terminal polymerization domain. Thrombos. Res 1977; 9: 25-36. 21 Lane D. A, Ireland H, Thrompson E, Southan C, Kehl M, Henschen A. Further structural and functional studies on a heterogenous abnormal fibrinogen, fibrinogen Manchester. Br. J. Haemat 1982; 52: 138 22 Ménaché D. Dysfibrinogénémie constitutio-nelle et familiale. Proc. 9th Congr. Eur. Soc. Hemat. 1963: 1255 23 Mester L, Szabados L. Structure défectueuse et biosynthèse des fractions glucidiques dans les variantes pathologiques du fibrinogène. Nouv. Rev. Franç. Hématol 1970; 10: 679-684. 24 Morris S, Denninger M. H, Finlayson J. S, Ménaché D. Fibrinogen Lille: AA 7 ASP→ASN. Thrombos. Haemostas 1981; 46: 104 25 Morse E. E. The fibrinogenopathies. Ann. Clin. Lab. Sci 1978; 8: 234-238. 26 Palascak J. E, Martinez J. Dysfibrinogenemia associated with liver disease. J. Clin. Invest 1977; 60: 89-95. 27 Ratnoff O. D, Forman W. B. Criteria for the differentiation of dysfibrinogenemic states. Semin. Hematol 1976; 13: 141-157. 28 Rupp C, Kuyas C, Häberli A, Furlan M, Perret B. A, Beck E. A. Fibrinogen Bern I: A hereditary fibrinogen variant with defective conformational stabilization by calcium ions. In Henschen A, Graeff H, Lottspeich F. (Hrsg.) Fibrinogen – Recent Biochemical and Medical Aspects De Gruyter; Berlin/New York: 1982: S.167-181. 29 Rupp C, Beck E. A. Congenital dysfibrinogenemia. In Beck E. A, Furlan M. (Hrsg.) Variants of Human Fibrinogen Huber; Bern/Stuttgart/Wien: 1983. im Druck 30 Southan C, Henschen A, Lottspeich F. The search for molecular defects in abnormal fibrinogens In Henschen A, Graeff H, Lottspeich F. (Hrsg.) Fibrinogen – Recent Biochemical and Medical Aspects De Gruyter; Berlin/New York: 1982: S. 154-166. 31 von Feiten A, Straub P. W, Frick P. G. Dysfibrinogenemia in a patient with primary hepatoma; first observation of an acquired abnormality of fibrin monomer aggregation. N. Engl. J. Med 1969; 280: 405-409.
